Can-Fite BioPharma Ltd. EV - Enterprise Value 2011-2026 | CANF

Annual EV - Enterprise Value Can-Fite BioPharma Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	647 M	701 M	189 M	705 M	1.22 B	782 M	765 M	851 M	36.8 M	28 M	1.61 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.22 B	1.61 M	539 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Adagene ADAG	395 M	$ 1.65	7.91 %	$ 92.9 M	China
AstraZeneca PLC AZN	57.7 B	$ 93.52	-1.2 %	$ 96.9 B	Britain
Autolus Therapeutics plc AUTL	1.11 B	$ 1.52	-16.3 %	$ 388 M	Britain
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.59	1.99 %	$ 8.64 B	Australia
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Biogen BIIB	28.3 B	$ 184.48	-1.67 %	$ 26.9 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	-6.64 B	$ 102.17	2.32 %	$ 27.2 B	Germany
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Ascendis Pharma A/S ASND	726 M	$ 207.49	2.22 %	$ 5 B	Danmark
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Catalyst Biosciences CBIO	38.1 M	$ 10.84	0.46 %	$ 714 M	USA
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
Corcept Therapeutics Incorporated CORT	6.58 B	$ 37.35	-0.4 %	$ 3.86 B	USA
Aeglea BioTherapeutics AGLE	725 M	-	-	$ 1.01 B	USA
Catalyst Pharmaceuticals CPRX	2.05 B	$ 23.18	2.02 %	$ 2.75 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Celldex Therapeutics CLDX	18.3 M	$ 25.59	-6.54 %	$ 1.65 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Cellectis S.A. CLLS	109 M	$ 4.22	-4.2 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	2 B	$ 29.43	6.09 %	$ 1.43 B	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	3.22 B	$ 9.66	2.28 %	$ 1.53 B	Britain
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Arrowhead Pharmaceuticals ARWR	6.02 B	$ 66.05	2.3 %	$ 8.83 B	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Crinetics Pharmaceuticals CRNX	2.55 B	$ 55.11	3.49 %	$ 4.45 B	USA
Abeona Therapeutics ABEO	184 M	$ 5.14	-1.06 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	3.35 B	$ 55.17	2.47 %	$ 4.65 B	Schweiz
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	41.5 B	$ 632.29	0.09 %	$ 47.9 B	USA
ADiTx Therapeutics ADTX	23.1 M	$ 0.81	1.96 %	$ 10.7 K	USA
Aytu BioScience AYTU	-15.2 M	$ 2.7	2.27 %	$ 17 M	USA